New Jersey lawmakers passed a bill to establish a $6 million psilocybin therapy pilot program, which has been sent to Gov. Phil Murphy. The measure creates an 11-member Psychedelic Therapy and Research Advisory Board to oversee the Psilocybin Behavioral Health Services Pilot Program, which will study the substance's efficacy in treating behavioral health conditions like depression, anxiety, and substance use disorders in three participating hospitals.

New Jersey Passes Psilocybin Therapy Pilot Program Bill

Jan 13, 2026

Source:

Tom Angell

Marijuana Moment

New Jersey is taking a major step toward embracing the therapeutic potential of psychedelics. Lawmakers just passed a bill to launch a $6 million psilocybin therapy pilot program, now awaiting Governor Phil Murphy's signature. This initiative will fund clinical trials at three hospitals to study how "magic mushrooms" can help treat conditions like depression and anxiety. An 11-member advisory board will be established to oversee the program and eventually provide a roadmap for future state-wide regulations.

While the original proposal for broad adult-use legalization was scaled back to this clinical focus, it represents a massive win for the community. For regular tokers and wellness seekers, this program is a huge deal because it validates the medical benefits of plant-based medicine and sets the stage for safer, legal access down the road. Seeing a state move toward research-backed psychedelic therapy is a clear sign that the war on plants is crumbling, paving the way for a more open and health-focused culture for everyone.